Charcot-Marie-Tooth Disease Type 2E (CMT2E)

Charcot-Marie-Tooth disease type 2E (CMT2E) is a rare, inherited nerve disease that mainly damages the long “wires” of the peripheral nerves, called axons. These nerves carry signals from the spinal cord to the muscles and from the skin back to the brain. When the axons are injured, the signals become weak or slow, and the muscles and sensation in the feet and hands slowly get worse over many years. CMT2E is part of the large Charcot-Marie-Tooth (CMT) group, which are hereditary motor and sensory neuropathies. All CMT types cause weakness and wasting in the distal (far) parts of the limbs, reduced reflexes, and different levels of sensory loss. Wikipedia+1

Charcot–Marie–Tooth disease type 2E (CMT2E) is a rare, inherited nerve disease that mainly damages the long nerves in the legs and arms. It is usually caused by changes (mutations) in a gene called INF2, which affects how the supporting cells around nerves handle a protein called actin. Because of this gene change, the nerve fibers that carry signals to the muscles slowly get weaker and thinner, especially in the feet and hands. People often develop high-arched feet, weak ankles, tripping, and difficulty with fine hand movements. At the moment, there is no cure and no treatment proven to stop or reverse the nerve damage, so care focuses on reducing symptoms, keeping muscles working as well as possible, and preventing complications like falls and foot deformities.NCBI+2

CMT2E is an “axonal” type of CMT2. In axonal CMT, the main problem is in the nerve fiber itself, not mainly in the myelin (the insulation around the nerve). Studies show that CMT2E is usually caused by changes (mutations) in the NEFL gene, which gives the instructions for a protein called neurofilament light chain. This protein helps form the internal skeleton of axons and is important for axon strength and transport of materials along the nerve. PubMed+1

CMT2E is usually inherited in an autosomal dominant pattern. This means that a person needs only one copy of the changed NEFL gene from either parent to develop the disease. The age at which symptoms start and how severe they are can be very different even inside the same family. Some people have mild foot weakness in adulthood, while others may show problems with walking in childhood and later need a wheelchair. National Organization for Rare Disorders+1

Other names

Charcot-Marie-Tooth disease type 2E is known by several other medical names. It is often called “Charcot-Marie-Tooth disease, axonal, type 2E,” which reminds doctors that the main damage is to the axon part of the nerve. Some databases also use “CMT2E (NEFL-related)” to highlight the link with the NEFL gene. MalaCards+1

Because mutations in the same NEFL gene can sometimes cause a demyelinating form of CMT called type 1F, you may also see “CMT2E/1F” or “NEFL-related CMT” used in scientific papers. These terms show that the same gene can lead to either axonal (2E) or demyelinating (1F) patterns, depending on the exact mutation. OUP Academic+1

More general terms such as “hereditary motor and sensory neuropathy due to NEFL mutation” or “NEFL-related hereditary neuropathy” may also be used, especially in genetics and research reports. PMC+1

Types (clinical patterns of CMT2E)

Doctors do not have official “subtypes” inside CMT2E like A, B, C, but clinical studies show several common patterns of how CMT2E can appear. One pattern is early-onset severe CMT2E, where symptoms such as low muscle tone, delayed walking, and marked foot deformities start in infancy or early childhood. These children can develop significant weakness and may need walking aids or a wheelchair in adolescence. ResearchGate+1

Another pattern is classic juvenile or young-adult CMT2E. In this group, symptoms usually start between late childhood and early adulthood. People first notice ankle weakness, frequent ankle sprains, or difficulty running. Over time, distal muscle wasting and sensory loss slowly spread up the legs and later affect the hands. Many people in this group stay able to walk independently for much of life. Muscular Dystrophy Association+1

There is also a late-onset mild form, where symptoms such as slight foot drop or reduced ankle reflexes appear in middle age or later. These individuals may have mild disability and may be discovered only when relatives are tested. PubMed+1

Some NEFL changes cause an intermediate or mixed form, where nerve conduction studies show features between demyelinating CMT1F and axonal CMT2E. In these cases, people may have more severe disability, sometimes with scoliosis or other neurologic signs. Rarely, NEFL mutations can be linked to complex phenotypes, including early hypotonia, ataxia, or features of Dejerine-Sottas syndrome. OUP Academic+2Wiley Online Library+2

Causes

1. Pathogenic NEFL gene mutation (main cause).
The core cause of CMT2E is a disease-causing mutation in the NEFL gene on chromosome 8. This mutation changes the neurofilament light chain protein so it can no longer support the internal structure and stability of axons, leading to chronic axonal damage in peripheral nerves. PubMed+1

2. Autosomal dominant inheritance from an affected parent.
Most people with CMT2E inherit the NEFL mutation from one affected parent. Because the disease is autosomal dominant, each child of an affected person has a 50% chance of inheriting the mutation and developing the neuropathy. National Organization for Rare Disorders+1

3. De novo NEFL mutation.
In some families, a person is the first one to have CMT2E because a new (de novo) mutation occurs in the egg or sperm or early embryo. The parents do not have CMT, but the child carries the NEFL mutation and can pass it on to their own children. neurofilament.osu.edu+1

4. Dominant-negative effect of mutant neurofilament.
Many NEFL mutations act in a “dominant-negative” way. The abnormal neurofilament protein combines with normal neurofilament proteins and disrupts the entire filament network inside the axon. This mis-assembly makes the axon fragile and prone to degeneration. OUP Academic+1

5. Disruption of axonal cytoskeleton.
Neurofilaments are key building blocks of the axonal cytoskeleton. When NEFL is altered, the neurofilament network becomes disorganized and swollen. This structural disturbance narrows or blocks the axon, interfering with signal conduction and causing distal axonal degeneration. PubMed+1

6. Impaired axonal transport.
Axons depend on long-distance transport to move nutrients, mitochondria, and proteins. Mutant neurofilaments can clog the axon and disturb this transport system. Over time, the far ends of the nerves (in feet and hands) are starved of needed supplies, leading to “dying-back” neuropathy. PMC+1

7. Specific NEFL missense variants (e.g., E396K).
Certain specific amino-acid changes, such as E396K in NEFL, have been described repeatedly in unrelated families with CMT2E. These variants are strongly associated with axonal neuropathy and show variable clinical severity from mild to severe within and between families. ResearchGate+1

8. NEFL Pro22 variants.
Mutations affecting the Pro22 position of NEFL, such as Pro22Ser or Pro22Thr, can cause CMT2E or related NEFL neuropathies. These changes alter an important region for filament assembly, leading to giant axons or abnormal myelin patterns in some patients. Nature+1

9. Gene–environment interaction.
Although the NEFL mutation is the main cause, lifestyle and environmental factors like repeated nerve trauma, poorly fitted shoes, or chronic alcohol misuse may worsen nerve damage and speed up disability in people already carrying the mutation. neurofilament.osu.edu+1

10. Age-related axonal vulnerability.
With increasing age, axons naturally become more vulnerable. In CMT2E, the presence of mutant neurofilament means that age-related stress, such as oxidative damage or reduced repair capacity, can lead to faster loss of distal nerve fibers and progression of weakness. neurofilament.osu.edu+1

11. Mitochondrial stress secondary to cytoskeletal damage.
Abnormal neurofilaments can disturb the positioning and movement of mitochondria along the axon. This may reduce local energy supply in the nerve endings, leading to further axonal degeneration and clinical worsening. PMC+1

12. Modifier genes in other CMT-related pathways.
Some people with the same NEFL mutation have very different disease severity. Researchers suggest that other genes involved in axon maintenance, myelin health, or stress responses can modify how strongly the NEFL mutation shows itself. PMC+1

13. Coexisting neuropathy causes (e.g., diabetes).
If a person with CMT2E also develops another condition that damages peripheral nerves, such as diabetes or severe vitamin deficiency, the combined effects can cause faster decline in strength and sensation than CMT2E alone. MedlinePlus+1

14. Poor ankle and foot protection.
Without good foot care and brace support, repeated ankle sprains and pressure points may injure already weakened nerves and muscles. Over time, this mechanical stress can worsen deformities and functional disability in CMT2E. Muscular Dystrophy Association+1

15. Sedentary lifestyle and deconditioning.
If a person with CMT2E avoids physical activity because of fear of falls or fatigue, muscles can become weaker from disuse on top of nerve damage. This secondary deconditioning can make walking and hand tasks even harder, though moderate, safe exercise is usually encouraged. Muscular Dystrophy Association+1

16. Excess weight and joint overload.
Carrying extra body weight puts more stress on already unstable ankles, knees, and hips. In CMT2E, obesity can worsen pain, fatigue, and the risk of falls, even though it does not cause the genetic disease itself. neurofilament.osu.edu+1

17. Incorrect footwear.
Shoes without good support, or with high heels, can increase ankle instability and pressure on deformed feet. In people with CMT2E and weak ankle muscles, this can lead to more falls and additional nerve compression. Muscular Dystrophy Association+1

18. Delayed diagnosis and lack of early rehabilitation.
If CMT2E is not recognized early, patients may not receive braces, physical therapy, or occupational therapy when they first need them. This delay can allow contractures and deformities to develop, increasing long-term disability. neurofilament.osu.edu+1

19. Smoking-related vascular effects.
Smoking damages blood vessels and reduces oxygen delivery. In a disease where axons are already fragile, reduced blood supply to nerves and muscles may further accelerate neuropathy and muscle loss. neurofilament.osu.edu+1

20. Psychosocial stress and lack of support.
Chronic stress, depression, and lack of social support do not directly cause CMT2E, but they can reduce motivation to exercise, attend therapy, or use braces. This can indirectly worsen functional outcomes and quality of life in people living with this inherited neuropathy. neurofilament.osu.edu+1

Symptoms

1. Progressive distal muscle weakness.
The most typical symptom of CMT2E is slowly increasing weakness in the muscles furthest from the body, especially around the ankles and feet at first. People may notice trouble standing on their toes or heels, running, or climbing stairs. Muscular Dystrophy Association+1

2. Foot drop and high-stepping gait.
Weakness of the muscles that lift the foot causes “foot drop.” The toes drag or hit the ground when walking, so people often lift their knees higher to clear the foot, creating a high-stepping gait pattern. Wikipedia+1

3. Foot deformities (pes cavus, hammertoes).
Over time, imbalance between weak and relatively stronger muscles pulls the foot into a high-arched shape (pes cavus) and causes curled toes (hammertoes). These deformities can cause shoe problems, calluses, and pain. Wikipedia+1

4. Distal muscle wasting.
The muscles in the lower legs and sometimes the hands gradually shrink because they are not properly activated by the damaged nerves. This gives a “stork leg” or “inverted champagne bottle” look, with thin calves and relatively normal thighs. Muscular Dystrophy Association+1

5. Reduced or absent deep tendon reflexes.
Reflexes such as the ankle jerk are often weak or absent because the nerve loop between muscle and spinal cord is interrupted. Doctors use a reflex hammer and may find little or no response, especially at the ankles. Muscular Dystrophy Association+1

6. Distal sensory loss.
Many people with CMT2E notice numbness, tingling, or reduced feeling in the feet and later in the hands. They may not sense light touch, pain, temperature, or vibration normally, especially in the toes and soles. PMC+1

7. Poor balance and frequent falls.
Loss of sensation in the feet and weakness of ankle muscles make it hard to know where the feet are and to keep balance, especially in the dark or on uneven ground. This leads to unsteadiness and a higher risk of tripping and falling. CMT Research Foundation+1

8. Hand weakness and fine motor difficulty.
Later in the course of CMT2E, the small muscles of the hands can weaken. People may struggle with tasks like buttoning clothes, writing, using zippers, or opening jars because of loss of grip strength and coordination. MalaCards+1

9. Neuropathic pain or discomfort.
Some patients report burning, shooting, or electric-like pain in the feet or legs, due to damaged sensory nerves. Others feel aching, cramps, or restless sensations, especially after long periods of standing or walking. PMC+1

10. Muscle cramps and fatigue.
Weak muscles must work harder to perform normal activities. This leads to easy fatigue, muscle cramps, and a feeling of heaviness in the legs, especially after walking longer distances or climbing stairs. Muscular Dystrophy Association+1

11. Scoliosis or spinal deformity (in some cases).
In some people with NEFL-related CMT, especially with early-onset disease, weakness and imbalance of trunk muscles may contribute to spinal curvature (scoliosis), which can cause back pain or cosmetic concerns. MalaCards+1

12. Tremor or shakiness (occasionally).
A few patients with CMT2 or NEFL-related CMT can develop a fine hand tremor. This may be due to involvement of sensory pathways and motor control circuits, although it is not present in everyone. neurofilament.osu.edu+1

13. Delayed motor milestones in childhood.
Children with early-onset CMT2E may sit, stand, or walk later than expected. Parents may notice floppy muscles (hypotonia) in infancy, late walking, or an awkward gait once the child starts to move independently. ResearchGate+1

14. Autonomic features in some patients.
Some reports mention mild problems with sweating, cold intolerance, or other autonomic symptoms in a few NEFL-related cases, though this is not a major feature for most people with CMT2E. MalaCards+1

15. Emotional and social impact.
Living with progressive weakness, visible foot deformity, and risk of falls can cause anxiety, low mood, or social withdrawal. People may avoid activities they once enjoyed and worry about passing the condition to their children. neurofilament.osu.edu+1

Diagnostic tests

Physical examination–based tests

1. Detailed neurological examination.
A neurologist carefully checks muscle strength, tone, reflexes, and sensation in the arms and legs. In CMT2E, they typically find distal weakness, muscle wasting, reduced or absent ankle reflexes, and length-dependent sensory loss, while proximal muscles are relatively preserved. Muscular Dystrophy Association+1

2. Gait and balance assessment.
The doctor watches how the person walks, turns, and stands on heels or toes. A high-stepping gait, foot slapping, difficulty heel-walking, and unsteadiness when the eyes are closed are common signs of CMT-type neuropathies including CMT2E. Muscular Dystrophy Association+1

3. Examination of foot and skeletal alignment.
Inspection of the feet can show pes cavus, hammertoes, calluses, and ankle instability. The spine is also checked for scoliosis. These physical signs support the diagnosis of a long-standing hereditary neuropathy. Wikipedia+1

4. Functional mobility and daily-living assessment.
Simple bedside tests like rising from a chair without using hands, climbing a few steps, or performing a timed walk help measure how much the neuropathy affects daily life. This helps plan braces, therapy, and fall-prevention strategies. neurofilament.osu.edu+1

Manual bedside tests

5. Manual muscle testing (MMT).
The examiner grades muscle strength at the ankles, toes, knees, wrists, and fingers by asking the patient to move against resistance. In CMT2E, ankle dorsiflexors and toe extensors are usually weakest, often before more proximal groups are affected. Muscular Dystrophy Association+1

6. Sensory testing (light touch, pin, vibration, position).
Using cotton, a pin, tuning fork, or by moving a toe up and down, the doctor checks touch, pain, vibration, and joint position sense. In CMT2E, loss usually begins in the toes and moves upward, reflecting length-dependent axonal sensory neuropathy. PMC+1

7. Deep tendon reflex testing.
Reflexes at the ankle, knee, elbow, and biceps are tested with a reflex hammer. CMT2E typically shows reduced or absent ankle reflexes and sometimes reduced knee reflexes, which help distinguish neuropathy from primary muscle disease. Muscular Dystrophy Association+1

8. Romberg and tandem gait tests.
In the Romberg test, the patient stands with feet together and eyes closed; increased sway or falling suggests sensory ataxia. Walking heel-to-toe in a straight line (tandem gait) can also reveal balance problems linked to distal sensory loss in CMT2E. CMT Research Foundation+1

Lab and pathological tests

9. Basic blood tests to exclude acquired neuropathies.
Tests such as complete blood count, blood sugar, kidney and liver function, vitamin B12, thyroid tests, and serum protein electrophoresis are done mainly to rule out other, treatable causes of neuropathy. Normal results support a hereditary cause like CMT2E. MedlinePlus+1

10. Genetic testing panel for CMT.
Modern practice often uses next-generation sequencing panels that examine many CMT-related genes at once, including NEFL. Finding a known pathogenic NEFL variant in a person with compatible clinical features confirms the diagnosis of NEFL-related CMT2E. neurofilament.osu.edu+1

11. Targeted NEFL sequencing or exome/genome sequencing.
If a CMT panel is negative or not available, targeted sequencing of NEFL, whole-exome, or whole-genome sequencing may be used. These tests can detect rare or novel NEFL mutations, allowing accurate genetic counseling for families. ResearchGate+1

12. Nerve biopsy with histopathology (selected cases).
In difficult cases, a small piece of peripheral nerve (often sural nerve) may be removed for microscopic study. In axonal CMT2E, biopsy may show loss of large myelinated fibers and axonal degeneration, sometimes with abnormal neurofilament accumulations. Today, biopsy is less common due to advanced genetic testing. PubMed+1

Electrodiagnostic tests

13. Nerve conduction studies (NCS).
NCS measure the speed and strength of electrical signals along motor and sensory nerves. In CMT2E, motor conduction velocities are usually normal or only mildly reduced, while response amplitudes are decreased, indicating axonal loss rather than primary demyelination. MalaCards+1

14. Electromyography (EMG).
EMG uses a fine needle electrode inserted into muscles to record electrical activity. In CMT2E, EMG commonly shows chronic denervation and reinnervation, with large motor units in distal muscles, confirming a chronic axonal motor neuropathy. Muscular Dystrophy Association+1

15. F-wave and H-reflex studies.
These specialized nerve conduction responses test the integrity of the whole motor pathway from muscle to spinal cord and back. They may be delayed or absent in CMT2E, reflecting loss or dysfunction of the longest motor fibers, especially in the legs. Orthobullets+1

16. Somatosensory evoked potentials (SSEPs).
SSEPs record the brain’s response to small electrical stimuli applied to nerves in the limbs. In length-dependent axonal neuropathies like CMT2E, SSEPs from the legs may be delayed or reduced, showing impaired sensory signal conduction along long pathways. neurofilament.osu.edu+1

Imaging tests

17. X-rays of feet and spine.
Plain radiographs can demonstrate bone changes related to long-standing neuropathy, such as high arches, hammertoes, ankle instability, and sometimes scoliosis. These images help orthopedic surgeons plan braces or corrective surgery if needed. Wikipedia+1

18. MRI of spine and nerve roots.
Magnetic resonance imaging of the spine and nerve roots is usually normal in CMT2E but can exclude other causes of weakness and sensory loss, such as spinal cord compression or inflammatory radiculopathy, which may require different treatment. neurofilament.osu.edu+1

19. MRI of peripheral nerves (MR neurography).
In some centers, high-resolution MR neurography is used to visualize peripheral nerves. It may show mild nerve enlargement or signal changes in hereditary neuropathies, although this is mainly a research and specialized diagnostic tool. neurofilament.osu.edu+1

20. Ultrasound of peripheral nerves and muscles.
Nerve and muscle ultrasound uses sound waves to show nerve size and muscle bulk. In axonal CMT2E, nerves may be normal or slightly enlarged, and muscles may appear thinner from atrophy. Ultrasound is painless and can help monitor muscle wasting over time. neurofilament.osu.edu+1

Non-pharmacological treatments (therapies and others)

Below are key non-drug treatments that research and guidelines support for CMT in general (and are also used for CMT2E). None of them cures the disease, but together they can greatly improve function and quality of life.PMC+2ScienceDirect+2

1. Physiotherapy (physical therapy)
   Physiotherapy is one of the most important treatments for CMT2E. A physiotherapist designs safe exercises to keep muscles strong, prevent joint stiffness, and maintain balance. This often includes stretching, strengthening, and gentle aerobic work like walking or swimming. The purpose is to slow loss of function, reduce contractures, and lower the risk of falls. The main mechanism is simple: regular, guided movement keeps muscles and joints working, improves blood flow, and trains the nervous system to use remaining nerve pathways more efficiently.PMC+2Physiopedia+2

2. Occupational therapy
   Occupational therapists help people with CMT2E manage daily activities such as dressing, writing, cooking, and computer use. They may suggest adaptive tools (larger grips, special keyboards, button hooks) to make tasks easier and safer. The purpose is to keep independence at home, school, or work for as long as possible. Mechanistically, occupational therapy works by modifying tasks and environments to fit the person’s abilities, rather than forcing the body to do difficult movements that could cause pain, fatigue, or injury.NCBI+1

3. Ankle–foot orthoses (AFOs) and bracing
   Many people with CMT2E have “foot drop,” where the front of the foot drags. AFOs are light braces worn inside shoes that hold the ankle at a safe angle and lift the toes during walking. The purpose is to improve walking speed, stability, and safety, and to reduce tripping. AFOs work mechanically by controlling ankle position and supporting weak muscles, so the leg does not need to work as hard. They also help prevent long-term deformities in the foot and ankle.Pod NMD+1

4. Custom footwear and insoles
   High-arched feet, clawed toes, and loss of feeling can lead to pressure points and skin damage. Custom shoes, soft insoles, and toe supports spread pressure more evenly across the foot. The purpose is to reduce pain, prevent calluses and ulcers, and improve balance. The mechanism is mainly mechanical: better support under the foot changes how forces pass through the foot and ankle during standing and walking, which protects joints and skin.Patient.info+1

5. Strengthening and resistance exercises
   Supervised resistance exercises using bands, light weights, or body weight can help preserve muscle strength in arms and legs that still have working nerve supply. The purpose is not to “build big muscles,” but to slow weakness and keep daily activities easier. The mechanism is similar to other strength training: repeated use of a muscle encourages it to maintain size and function, but in CMT it must be low-intensity and carefully monitored to avoid over-fatigue of already weak nerves.PMC+1

6. Stretching and range-of-motion exercises
   When muscles are weak, joints can become stiff and tendons can shorten, leading to fixed deformities. Gentle, regular stretching of ankles, knees, fingers, and toes helps maintain flexibility. The purpose is to prevent contractures, reduce pain, and keep walking and hand use possible for longer. The mechanism is that slow stretching of muscles and tendons helps them stay longer and more elastic, which keeps joints moving smoothly and reduces abnormal pressure on bones.Physiopedia+1

7. Balance and gait (walking) training
   Physiotherapists often use specific exercises to train balance and walking, sometimes with parallel bars or support devices. The purpose is to reduce falls, improve confidence, and teach safer walking patterns. Mechanistically, these exercises push the body to practice balance in a controlled way, so the brain learns to compensate for weak muscles and reduced sensation by using visual and inner-ear feedback more effectively.Physiopedia+1

8. Hand therapy and fine motor training
   CMT2E can weaken the small muscles of the hands, making grip and coordination difficult. Hand therapists use exercises, splints, and adaptive devices to support the fingers and thumbs. The purpose is to preserve handwriting, using tools, and other fine tasks. The mechanism is similar to leg therapy: repeated, targeted tasks strengthen available muscles, train alternative movement patterns, and reduce joint stress.NCBI+1

9. Pain psychology and cognitive-behavioural therapy (CBT)
   Chronic pain and fatigue can affect mood and sleep. CBT and other psychological therapies teach coping skills, relaxation, pacing, and ways of thinking that reduce suffering even when pain cannot fully disappear. The purpose is to improve quality of life, not to say the pain is “imagined.” The mechanism is that thoughts, emotions, and behaviour can change how the brain processes pain signals, lowering the perceived intensity and improving daily function.ScienceDirect

10. Assistive walking devices (canes, crutches, walkers)
    When balance or strength is poor, a cane, crutch, or walker can add stability. The purpose is to reduce falls and increase independence, especially outdoors or on uneven ground. Mechanistically, these devices add extra points of contact with the ground and share body weight, so weak ankles and knees are less stressed and the body can stay upright more easily.Patient.info+1

11. Home modifications and fall-prevention strategies
    Simple home changes—grab bars, non-slip mats, removing loose rugs, better lighting—make a big difference. The purpose is to prevent fractures and head injuries from falls. The mechanism is environmental: instead of changing the body, we change the surroundings to remove hazards, so even someone with weak feet and poor sensation can move more safely.Patient.info

12. Podiatry (specialist foot care)
    Regular visits to a podiatrist help manage nails, calluses, and pressure points. The purpose is to prevent wounds and infections, which can be serious when sensation is reduced. Mechanistically, removing hard skin, choosing proper footwear, and monitoring for early problems all protect the skin and bones of the feet.ScienceDirect

13. Weight management and low-impact aerobic exercise
    Extra body weight puts more stress on weak feet, ankles, and knees. Gentle aerobic activities like swimming, cycling, or water aerobics help control weight and improve heart and lung health. The mechanism is metabolic: regular aerobic activity improves energy use, mood, and sleep, which all support overall function in CMT2E.PMC+1

14. Energy conservation and fatigue management
    Fatigue is common in CMT because weak muscles work harder. Occupational therapists teach pacing (spreading tasks through the day), using rests, and choosing priorities. The purpose is to avoid over-tiredness that worsens weakness and pain. The mechanism is simple: by planning activity and rest, the nervous and muscular systems are less overloaded, and symptoms are more stable.ScienceDirect+1

15. Mental health support and counselling
    Living with a chronic genetic disease can lead to anxiety, sadness, or depression. Talking with a psychologist or counsellor can help manage these feelings, support families, and improve coping skills. The mechanism is emotional and social: good mental health support reduces stress hormones, improves sleep, and strengthens motivation to follow therapies and exercise plans.ScienceDirect+1

16. Genetic counselling
    Because CMT2E is genetic, families often want to understand inheritance patterns and options for future pregnancies. Genetic counsellors explain the risk to children and relatives, possible testing, and the limits of current science. The mechanism here is informed decision-making: by understanding the gene change, families can make choices that fit their values and plans.NCBI+1

17. Education and self-management training
    Learning about CMT2E—what it is, what to expect, and how to protect the body—is itself a therapy. Education programs and patient organisations provide information and peer support. The mechanism is empowerment: when people know what is happening and what they can do, they make healthier choices and use health services more effectively.PMC+1

18. Sleep hygiene strategies
    Pain, cramps, and worry can disturb sleep in CMT2E. Good sleep habits—regular bedtimes, a calm routine, limiting screens and caffeine—help the brain and body recover each night. The mechanism is that deeper, more regular sleep lowers pain sensitivity, improves mood, and helps nerves and muscles work better during the day.ScienceDirect

19. Respiratory and posture training (for selected patients)
    A small number of people with more severe CMT may develop breathing or posture problems. Respiratory physiotherapy and posture exercises help keep chest muscles moving and spine alignment better. The purpose is to prevent breathing complications and severe spinal deformity. The mechanism is repeated activation of breathing and trunk muscles, which maintains strength and lung expansion.NCBI+1

20. Support groups and patient organisations
    Meeting others with CMT can reduce loneliness and provide practical tips. Support groups often share experiences about braces, therapies, and coping with school or work. The mechanism is social: feeling understood and supported reduces stress and increases adherence to beneficial treatments.PMC+1

---

Drug treatments

Very important: There is no drug that is approved specifically to cure or slow CMT2E. Medications are used to treat symptoms like neuropathic pain, cramps, mood problems, or sleep issues. The main evidence for these drugs comes from studies in other neuropathic conditions such as postherpetic neuralgia and diabetic neuropathy, and their official dosing information is taken from FDA-approved labels.PMC+2ScienceDirect+2

Because of space, I will describe 10 key medicines in more detail (each representing a useful class). Others are often used similarly. In real life, dosing and timing must follow the official label and your doctor’s advice, especially in children or people with kidney or liver problems.

1. Gabapentin (e.g., Neurontin, Gralise)
   Class: Anticonvulsant/neuropathic pain agent.
   Gabapentin is widely used to treat nerve pain in conditions like postherpetic neuralgia and diabetic neuropathy and is often chosen for painful CMT. It acts on calcium channels in nerve cells, reducing the release of excitatory chemicals involved in pain signalling. It is usually taken by mouth in divided doses over the day, with the total daily dose slowly increased according to the FDA label and doctor guidance. The purpose is to reduce burning, stabbing, or shooting pain and improve sleep. Common side effects include dizziness, sleepiness, and sometimes weight gain or swelling in the legs.FDA Access Data+2FDA Access Data+2

2. Pregabalin (e.g., Lyrica, Lyrica CR)
   Class: Anticonvulsant/neuropathic pain agent.
   Pregabalin is closely related to gabapentin and is approved for several neuropathic pain conditions. It binds to the α2δ subunit of voltage-gated calcium channels, reducing abnormal nerve firing and pain transmission. It is taken by mouth one to three times daily, with dose and schedule based on the FDA label and adjusted for kidney function. In CMT2E, doctors may use it off-label to reduce neuropathic pain and improve sleep. Common side effects are dizziness, drowsiness, blurred vision, and weight gain or ankle swelling.FDA Access Data+2FDA Access Data+2

3. Duloxetine (Cymbalta)
   Class: Serotonin–noradrenaline reuptake inhibitor (SNRI) antidepressant and neuropathic pain drug.
   Duloxetine is approved for diabetic neuropathic pain, chronic musculoskeletal pain, and depression. It increases the levels of serotonin and noradrenaline in the central nervous system, which modulates pain pathways and mood. In CMT2E, doctors may use it to manage chronic nerve pain plus low mood or anxiety. It is usually taken once daily, with dose chosen according to the FDA label and patient tolerance. Side effects can include nausea, dry mouth, sweating, increased blood pressure, and, rarely, liver or serious mood-related problems.FDA Access Data+2FDA Access Data+2

4. Tricyclic antidepressants (e.g., amitriptyline, nortriptyline)
   Class: Tricyclic antidepressant/neuropathic pain agents.
   Tricyclics are older antidepressants that, at low doses, are commonly used for chronic neuropathic pain. They block reuptake of serotonin and noradrenaline and have additional effects on sodium and calcium channels, which can dampen pain signals. In CMT2E, they are sometimes used at bedtime to help pain and sleep. Dosing is usually once at night and carefully increased in adults; they are used cautiously or not at all in some young people or those with heart problems. Side effects can include dry mouth, constipation, blurred vision, weight gain, and heart rhythm changes.ScienceDirect+1

5. Topical lidocaine 5% patch or gel
   Class: Local anaesthetic.
   Lidocaine patches are approved for postherpetic neuralgia and are used off-label on painful areas of skin in other neuropathies. They work by blocking sodium channels in peripheral nerves, temporarily reducing the ability of those nerves to send pain signals. In CMT2E, they may be used on localised painful spots, for a limited number of hours per day as directed on the label. Because lidocaine is mostly acting in the skin, systemic side effects are usually low, but skin irritation or rash may happen.FDA Access Data+1

6. Topical capsaicin (including high-strength patches)
   Class: TRPV1 receptor agonist (neuro-desensitising agent).
   Capsaicin is derived from chilli peppers and is used in creams or patches to treat nerve pain. It initially activates pain fibres, then causes them to become less sensitive by reducing certain pain-related chemicals. In CMT2E, doctors may use capsaicin for small, localised areas of burning pain. Application schedules follow the product label, and treatment is usually done under medical advice for high-strength patches. The main side effect is burning or stinging at the application site, which usually settles with time.ScienceDirect+1

7. Simple analgesics (paracetamol/acetaminophen)
   Class: Non-opioid analgesic.
   Paracetamol is a basic pain reliever that can help mild or moderate discomfort but usually does not control severe neuropathic pain alone. It appears to work mainly in the central nervous system by affecting pain and temperature regulation. In CMT2E, it may be used as a first-line or add-on medicine for general aches, following the dosing limits on the label to avoid liver damage. Side effects are usually mild but overdose can cause serious liver injury, so maximum daily dose limits must be respected.ScienceDirect+1

8. Non-steroidal anti-inflammatory drugs (NSAIDs, e.g., ibuprofen, naproxen)
   Class: NSAID analgesic/anti-inflammatory.
   NSAIDs reduce pain and inflammation by blocking cyclo-oxygenase (COX) enzymes that produce prostaglandins. They are more useful for joint or musculoskeletal pain around weak joints than for pure nerve pain. In CMT2E, they may be used short-term for ankle or knee pain under medical supervision. Dosing follows the approved label and must consider kidney, stomach, and heart risks. Side effects include stomach irritation, bleeding risk, kidney problems, and increased cardiovascular risk in some patients.ScienceDirect+1

9. Muscle relaxants (e.g., baclofen, tizanidine – in selected cases)
   Class: Antispasticity agents.
   Some people with CMT have troublesome cramps or spasticity-like symptoms. Drugs such as baclofen or tizanidine act on the spinal cord to reduce muscle over-activity, making muscles more relaxed. Doses are started low and slowly adjusted. They can help sleep and daily comfort but may cause drowsiness, weakness, or low blood pressure, which can be risky in someone already weak. They are used only when clearly needed and under close medical supervision.ScienceDirect

10. Antidepressants and anxiolytics for mood and sleep (e.g., SSRIs, low-dose sedating agents)
    Class: Antidepressants and anti-anxiety medicines.
    Living with CMT2E can affect mental health. Selective serotonin reuptake inhibitors (SSRIs) or other agents may be prescribed to treat depression or anxiety related to chronic illness. They work by adjusting the levels of brain chemicals involved in mood. Doses and timing follow each drug’s label. Side effects vary by drug but can include stomach upset, sleep changes, sexual side effects, or, rarely, serious mood changes. They treat mood, not the nerve damage itself, but better mood often improves pain coping and activity.ScienceDirect+1

Other medicines sometimes used symptomatically include tramadol or, rarely, other opioids (with strict caution), magnesium for cramps, and melatonin or other sleep aids. These always require careful risk–benefit discussion with a doctor, especially in teenagers.ScienceDirect+1

---

Dietary molecular supplements

Evidence for supplements in CMT2E is limited. Most data come from studies in diabetic neuropathy or general nerve health. Supplements should not replace medical care and can interact with medicines, so always discuss them with a doctor.ScienceDirect+1

1. Alpha-lipoic acid – An antioxidant that may reduce oxidative stress in nerves. It has been studied in diabetic neuropathy and may help burning pain and numbness. The mechanism involves scavenging free radicals and improving blood flow to nerves.

2. Acetyl-L-carnitine – A compound involved in energy production in mitochondria. It may support nerve regeneration and reduce pain by improving energy supply in damaged nerve cells.

3. Omega-3 fatty acids (fish oil) – These fatty acids have anti-inflammatory and membrane-stabilising effects. They may support general nerve cell health and cardiovascular health.

4. Vitamin B1 (thiamine) and benfotiamine – Important for glucose metabolism and nerve function. Deficiency can cause neuropathy, so correcting low levels is essential.

5. Vitamin B6 (pyridoxine) – Needed for many nerve chemical reactions, but high doses can themselves cause neuropathy, so it must be used only within safe limits and under supervision.

6. Vitamin B12 (methylcobalamin) – Crucial for myelin and DNA synthesis in nerves. Low B12 levels clearly damage nerves; correcting deficiency can improve symptoms in that case.

7. Vitamin D – Important for bone and muscle health. Adequate vitamin D may support muscle function and reduce falls by improving strength and balance.

8. Vitamin E – A fat-soluble antioxidant that protects cell membranes. Deficiency can cause neurological problems, and replacement in deficient people can help.

9. Coenzyme Q10 – A mitochondrial cofactor that may improve energy production and reduce oxidative stress in nerve and muscle cells. Evidence is limited but it is sometimes tried.

10. Curcumin (from turmeric) – Has anti-inflammatory and antioxidant properties. Experimental work suggests it can modulate inflammatory pathways; some patients use it as an add-on for general health.

For all of these, dose, form, and safety must follow product labels and doctor advice; “more” is not always better, and very high doses can be harmful.ScienceDirect+1

---

Regenerative, immunity-related and stem-cell approaches

Right now, no immune-booster, regenerative drug, or stem-cell product is approved to treat or cure CMT2E. Research is ongoing in broader CMT and other neuropathies.PMC+2ScienceDirect+2

Scientists are studying:

• Gene-targeted therapies – Approaches like gene silencing or editing are being tested in certain CMT subtypes (for example, CMT1A and CMT2S), but not yet approved for CMT2E.

• Neurotrophic factors – Laboratory and early clinical studies look at growth factors that support nerve survival, but results are not yet strong enough for routine care.

• Mesenchymal stem-cell therapies and other cell-based approaches – These are being explored in small trials for various neuropathies, with unclear long-term safety and benefit.

Because these approaches are experimental, there are no standard doses or schedules and they should only be accessed in ethically approved clinical trials, never through unregulated “stem-cell clinics.”

---

Surgical options

Surgery in CMT2E does not repair the damaged nerves, but it can correct deformities and improve function in selected patients.PMC+2Patient.info+2

1. Foot deformity correction (osteotomies and soft-tissue balancing)
   Surgeons may cut and reposition bones in the foot and adjust tendons to correct high arches and twisted feet. The goal is to create a more plantigrade (flat and stable) foot that fits into shoes and braces and reduces pain and skin breakdown.

2. Tendon transfer surgery
   Tendons from stronger muscles may be moved to take over the function of very weak muscles, such as those that lift the foot. The purpose is to improve active movement—for example, lifting the toes during walking—and reduce dependence on braces.

3. Joint fusion (arthrodesis) of ankle or small foot joints
   If joints are unstable or severely deformed and painful, they may be surgically fused in a better position so they no longer move. This sacrifices some flexibility but can provide a more stable, pain-free platform for walking.

4. Nerve decompression (e.g., carpal tunnel release)
   If compressed nerves (like median nerve at the wrist) add extra weakness and numbness on top of CMT2E, decompression surgery may help. The aim is to free the nerve from tight tunnels and improve symptoms not directly caused by the genetic neuropathy.

5. Spinal deformity correction (for significant scoliosis)
   In rare cases where muscle imbalance leads to severe spinal curvature, spinal fusion or corrective surgery may be offered. The purpose is to prevent progression, improve posture, and protect lung function.

---

Prevention and protection

CMT2E itself cannot be prevented because it is genetic, but complications can be reduced:Patient.info+1

1. Avoid known nerve-toxic medicines (such as certain chemotherapy drugs) whenever possible; doctors always weigh risks and discuss alternatives.

2. Protect feet with good shoes, daily skin checks, and prompt treatment of wounds.

3. Keep up with physiotherapy and stretching to prevent contractures and deformities.

4. Use braces or walking aids as advised to reduce falls and joint damage.

5. Maintain healthy body weight to lessen stress on weak feet and ankles.

6. Manage other conditions like diabetes, thyroid disease, or vitamin deficiencies that can worsen neuropathy.

7. Make home safety changes (good lighting, remove loose rugs, grab bars) to prevent falls.

8. Stay physically active within safe limits; avoid extreme, high-impact sports that risk injury.

9. Do not smoke and limit alcohol, as both can harm nerve health.

10. Use genetic counselling when planning a family to understand inheritance and options.

---

Diet: what to eat and what to avoid

Diet will not cure CMT2E, but good nutrition supports muscles, nerves, and overall health.ScienceDirect+1

What to eat (examples):

• Plenty of fruits and vegetables for vitamins, minerals, and antioxidants.

• Whole grains (brown rice, whole-wheat bread, oats) to keep energy steady.

• Lean proteins (fish, poultry, eggs, beans) to support muscle repair.

• Healthy fats, especially omega-3-rich foods like oily fish, flaxseed, and walnuts.

• Adequate calcium and vitamin D sources (dairy, fortified foods) for bone health.

• Enough fluids, mainly water, to prevent dehydration and muscle cramps.

What to avoid or limit (examples):

• Very sugary drinks and snacks that cause weight gain and energy swings.

• Foods high in trans-fats and deep-fried items, which promote inflammation.

• Excess alcohol, which can damage nerves and interact with medicines.

• Crash diets or severe calorie restriction, which can weaken muscles.

• Very high-dose unregulated supplements without medical supervision.

A dietitian with experience in neuromuscular diseases can tailor an eating plan to individual needs.

---

When to see doctors

People with CMT2E should have regular follow-up with a neurologist and rehabilitation team. It is especially important to see a doctor or contact your team if:NCBI+2Patient.info+2

• You notice sudden worsening of weakness, walking, or hand use.

• You develop new severe pain, burning, or numbness.

• You have frequent falls or near-falls.

• You see wounds, ulcers, or infections on your feet or legs.

• You develop breathing problems, chest tightness, or unusual shortness of breath.

• You experience new bladder or bowel problems or sudden back pain with weakness.

• Your mood becomes very low, or you have thoughts of hopelessness.

• Medicines or supplements cause worrying side effects.

Emergency services should be used for acute chest pain, severe breathing difficulty, sudden inability to move a limb, or serious injuries from falls.

---

Frequently asked questions (FAQs)

1. Is CMT2E the same as other types of CMT?
   No. CMT2E is one of many subtypes and is usually linked to mutations in the INF2 gene. All CMT types involve peripheral nerve damage, but the exact gene, pattern of inheritance, and severity can differ.NCBI+1

2. Can CMT2E be cured today?
   At present, no treatment has been proven to cure or halt CMT2E. Management focuses on rehabilitation, orthotics, occasional surgery, and medicines for symptoms such as pain and cramps. Research into gene and cell therapies is active but still experimental.PMC+2ScienceDirect+2

3. Will everyone with CMT2E need a wheelchair?
   Not always. Many people keep walking for years or decades, especially with early physiotherapy, braces, and foot care. Some may later use a wheelchair or scooter for longer distances to save energy and reduce falls. The course is very variable between individuals.NCBI+1

4. Is CMT2E life-threatening?
   Most people with CMT, including CMT2E, have a normal life expectancy, although disability can increase over time. Rarely, more severe forms or complications like serious falls, breathing problems, or severe scoliosis can affect health, which is why regular medical follow-up is important.NCBI+1

5. Can children or teenagers with CMT2E do sports?
   Yes, but usually low-impact activities are safest, such as swimming, cycling, or adapted games. High-impact or contact sports that risk ankle injuries or falls may not be suitable. A physiotherapist can help choose and adapt activities.Physiopedia+1

6. Is pregnancy safe for someone with CMT2E?
   Many people with CMT have successful pregnancies. Some may notice temporary worsening of symptoms due to weight gain and hormonal changes. Planning with a neurologist and obstetric team helps manage risks, and genetic counselling can explain chances of the baby inheriting CMT.NCBI+1

7. Should family members be tested for the INF2 gene change?
   Genetic testing decisions are personal. Some families choose testing to clarify diagnosis or for family planning; others prefer not to know. A genetic counsellor can explain benefits, limits, and possible emotional and insurance impacts of testing.NCBI+1

8. Do braces or orthoses make muscles weaker?
   Properly prescribed braces are designed to protect joints and improve walking, not to weaken muscles. In fact, by improving safety and alignment, they often allow more activity, which helps preserve strength. Physiotherapists balance use of braces with exercises to keep muscles working.Pod NMD+1

9. Can diet alone treat CMT2E?
   No. A good diet supports general health, but it cannot reverse the genetic nerve problem. However, poor diet and obesity can make things worse by adding joint stress and other illnesses, so healthy eating is still very important.ScienceDirect+1

10. Are alternative therapies (acupuncture, massage, etc.) useful?
    Some people find gentle massage, acupuncture, or relaxation therapies helpful for pain and stress. Scientific evidence is mixed, and these should never replace standard medical care, but they may be used alongside other treatments if safe and supervised.ScienceDirect

11. Which medicine is “best” for CMT2E pain?
    There is no single best medicine. Doctors usually start with drugs that have good evidence in other neuropathic pain conditions (gabapentin, pregabalin, duloxetine, or certain antidepressants) and adjust based on benefit and side effects. Often, more than one medicine must be tried to find a good fit.ScienceDirect+3FDA Access Data+3FDA Access Data+3

12. Is it safe to take many supplements together?
    Taking many supplements without medical advice can be unsafe, especially at high doses. Some interact with medicines or can harm organs like the liver or kidneys. Discuss all supplements with your doctor or pharmacist and avoid “mega-doses” unless specifically prescribed.ScienceDirect+1

13. Can CMT2E get better on its own?
    CMT2E is usually slowly progressive, meaning symptoms tend to get worse over time rather than better. However, with good therapy and lifestyle choices, many people have long periods where symptoms are stable and function is good.NCBI+1

14. Is research giving hope for the future?
    Yes. Research into gene therapies, small molecules, and cell-based therapies for different CMT types is active and has already led to early-phase trials in some subtypes. While nothing is approved yet for CMT2E, scientific understanding of INF2-related disease is growing, which may lead to targeted treatments in the future.PMC+2ScienceDirect+2

15. What is the most important thing I can do right now?
    For most people, the key steps are: stay followed by a neurologist and rehabilitation team, keep up with physiotherapy and orthotics, protect your feet and prevent falls, eat healthily, and care for your mental health. These simple, consistent actions often make the biggest difference in daily life with CMT2E.ScienceDirect+3PMC+3Physiopedia+3

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 29, 2025.